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ABSTRACT
More than 90% of human genes are rich in intronic
latent 50 splice sites whose utilization in pre-mRNA
splicing would introduce in-frame stop codons into
the resultant mRNAs. We have therefore hypothes-
ized that suppression of splicing (SOS) at latent
50 splice sites regulates alternative 50 splice site
selection in a way that prevents the production of
toxic nonsense mRNAs and verified this idea by
showing that the removal of such in-frame stop
codons is sufficient to activate latent splicing.
Splicing control by SOS requires recognition of
the mRNA reading frame, presumably recognizing
the start codon sequence. Here we show that AUG
sequences are indeed essential for SOS. Although
protein translation does not seem to be required for
SOS, the first AUG is shown here to be necessary
but not sufficient. We further show that latent
splicing can be elicited upon treatment with
pactamycin—a drug known to block translation by
its ability to recognize an RNA fold—but not by
treatment with other drugs that inhibit translation
through other mechanisms. The effect of pactamy-
cin on SOS is dependent neither on steady-state
translation nor on the pioneer round of translation.
This effect is found for both transfected and
endogenous genes, indicating that SOS is a natural
mechanism.
INTRODUCTION
One of the surprising realizations of the human genome pro-
ject was that a relatively small number of human genes give
rise to almost an order of magnitude larger number of pro-
teins (1,2). Bioinformatic as well as biochemical and genetic
analyses have revealed that most of this complexity of the
proteome can be achieved by alternative pre-mRNA splicing
(3,4). One route for generating alternative mRNA isoforms is
using alternative 50 splice sites. Mammalian 50 splice sites of
U2 spliceosomes are characterized by a consensus sequence
of 8 nt, AG/GTRAGT, where R denotes purine and ‘/’
denotes the splice junction (5,6). Based on alignment of
expressed sequence tag databases, alternative 50 splice site
selection can account for only  8% of the alternative splicing
events that are conserved between the human and the mouse
genomes (7). Evidently, this estimate is by far smaller than an
estimate derived from genomic sequence analyses. This dis-
crepancy has been reﬂected in a survey of a database com-
prising 446 human multi-exon annotated genes, where we
found that the abundance of 50 splice sites that conform to
the consensus but are not involved in splicing (hence termed
latent 50 splice sites) largely exceeds the number of authentic
50 splice sites that are used for both regular and alternative
splicing (8,9). The survey revealed 10490 intronic consensus
50 splice site sequences that are located within 1496 constitu-
tive introns, and 551 such sites were found within exons. This
means that an average of 4–6 latent splicing events at latent
50 splice sites can be expected for every splicing event at an
authentic site. Nonetheless, splicing events at latent 50 splice
sites have not been reported thus far, although the splice sig-
nal motive (10) of the latent splice sites does not differ from
that of the latent sites (8). It thus follows that compliance
with the consensus is not sufﬁcient to deﬁne a given sequence
as a functional 50 splice site.
This survey also showed that almost all latent 50 splice sites
(95.8%) are preceded by a stop codon that is in the reading
frame of the upstream exon. We have previously hypothes-
ized that the necessity to avoid the inclusion of premature ter-
mination codons within spliced mRNAs may serve as a
criterion that differentiates authentic from latent 50 splice
sites. According to this hypothesis, a nuclear scanning mech-
anism brings about the suppression of splicing (SOS) at latent
sites when they are preceded by an intronic in-frame stop
codon (11,12), thereby serving as a protection mechanism
against aberrant protein synthesis. The SOS hypothesis was
evaluated by a statistical analysis showing that the abundance
of in-frame stop codons upstream of latent 50 splice sites is
signiﬁcantly higher than that in introns that do not harbor
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An experimental clue for SOS was provided by mutational
analyses, whereby it was shown that sense mutations of
intronic in-frame stop codons upstream of latent 50 splice
sites were sufﬁcient to render such latent sites as active in
splicing (12). Furthermore, eliminating in-frame stop codons
by frame-shift mutations elicited latent splicing, and silent
mutations (e.g. TGA to TAA or TAG) maintained the sup-
pression of latent splicing. These observations excluded the
possibility that interference with splicing control elements
[for references see Ref. (13)] may have led to latent splicing
in mutant constructs not having in-frame stop codons (12).
We also excluded the possibility that splicing at latent
50 splice sites might normally occur, but the nonsense
mRNAs thus obtained are rapidly and efﬁciently degraded
by the nonsense-mediated mRNA decay (NMD) pathway
(14–18). To this end, we conducted a comprehensive study
in which we have shown that SOS is a novel mechanism
distinct from the known RNA surveillance mechanisms
(19). First, SOS is distinct from NMD because it is not
abrogated by translation inhibitors and it is not affected by
siRNA-mediated downregulation of hUpf1 and hUpf2—two
key components of the NMD pathway. Second, SOS is dis-
tinct from nonsense-associated alternative splicing (NAS)
(17,20–26), because a mutant of hUpf1, which was shown
to abrogate NAS (26), did not activate latent splicing.
The apparent linkage between the necessity to maintain an
open reading frame (ORF) in mRNAs on one hand, and pre-
mRNA splicing on the other hand, is presumably brought
about by a general SOS mechanism that suppresses splicing
events involving intronic latent 50 splice sites—if they are
preceded by a stop codon in the reading frame of the
upstream exon. It therefore follows that for its effective
operation the SOS mechanism must recognize a reference
point that deﬁnes the reading frame. Potential candidates to
serve as such reference points are translational start codon
sequences. Here we conﬁrm this possibility by examining
the effect of mutating ATG sequences on eliciting latent
splicing in pre-mRNAs transcribed from constructs encoding
the CAD gene. In particular, we show that the translation
initiation codon sequence is necessary, but not sufﬁcient, to
sustain SOS in a manner that is distinct from its role in
protein synthesis.
MATERIALS AND METHODS
Plasmids
CAD1, CAD2 (a variant of CAD1), CAD1-Mut9, CAD2-
Mut1 (constructs in which all in-frame stop codons were
eliminated) were prepared as described previously (12).
CAD constructs with mutated ATGs (Supplementary Table
1S) were prepared from CAD1 by the QuickChange PCR-
based mutagenesis method (Stratagene) (see Supplementary
Data). Wild-type and mutant IDUA mini gene constructs
were described (12). All constructs were conﬁrmed by
DNA sequencing.
pcDNA-3HA-4E-BP1, a plasmid carrying the human
4E binding protein1 (27,28), was kindly provided by
Dr Nahum Sonenberg (McGill University). pMT2-HA-eIF2a
plasmids (29) were kindly provided by Dr Paul Anderson
(Brigham and Women’s Hospital). A wild-type b-globin con-
struct (pmCMV-Gl-Normal) and a construct expressing a
PTC-containing b-globin mRNA (b-globin Ter39) (30) were
kindly provided by Dr Lynne E. Maquat, (University of
Rochester).
Transfections and RNA isolation
Human 293T or Syrian hamster 165-28 ﬁbroblast cells were
grown to 50% conﬂuency in tissue culture plates, transiently
cotransfected with the appropriate CAD (2–10 mg per 5 · 10
6
cells), 4E-BP1 or eIF2a (5 mg per 1 · 10
6 cells) DNA con-
structs and GFP-EA1 DNA (1 mg per 5 · 10
6 cells), and
total RNA was extracted 24 h post-transfection as described
previously (12). Treatment with pactamycin (3–10 mg/ml)
(kindly provided by Pﬁzer Inc), CHX (20 mg/ml), hygromy-
cin B (20 mg/ml) or tetracycline as a bacterial antibiotic con-
trol (20 mg/ml) was for 2–4 h at 24 h post-transfection, and
total RNA was extracted.
Small interfering RNA-mediated
downregulation of hUpf1
RNAi of hUpf1 using siRNA (Dharmacon) was performed as
described previously (19) according to Mendell et al. (26),
using siRNA targeted at ﬁreﬂy luciferase as a control. 293T
cells were grown to 30–50% conﬂuency in 6 cm plates in
DMEM medium without antibiotics, and siRNA was trans-
fected using oligofectamine (Invitrogen). After 48 h, the
medium was replaced by a medium with antibiotics, and
the cells were cotransfected with the appropriate CAD or
b-globin and GFP constructs for 24 h.
Western blots
Total proteins were analyzed by SDS–PAGE, blotted and
probed with antibodies against hUpf1 (kindly provided by
Drs Joshua Mendell and Harry Dietz, Johns Hopkins),
ADAR1 (kindly provided by Dr Kazuko Nishikura, Wistar
Institute), CBP80 (kindly provided by Dr Ian Mattaj,
EMBL) and 4E-BP1 (kindly provided by Dr Nahum
Sonenberg, McGill University).
RT–PCR
Total RNA was treated with RNase-free DNase I (50 U/ml;
Promega) and cDNA was synthesized from 2 mg RNA for
CAD and GFP, using dT15 primer and MMLV reverse tran-
scriptase (Gibco BRL). PCR (20 ml) contained cDNA syn-
thesized from 0.2 mg of total CAD RNA, 10 pmol of the
CAD or b-globin or b-actin primers, 1 pmol of the GFP pri-
mers (for primers list see Supplementary Data), and 1.0 U of
Taq DNA polymerase (Promega). Ampliﬁcation was carried
out in a Mastercycler (Eppendorf) for 30–35 cycles, at an
annealing temperature of 63 C for CAD primer pair a/b and
the b-globin primer pair; 62 C for CAD primer pair c/b; 59 C
for CAD primer pair j/k; 58 C for GFP; 60 C for b-actin and
58 C for hUpf1. PCR for hUpf1 were carried out in 2 mM
MgCl2.
RT–PCR analysis of the endogenous IDUA gene was car-
ried out with the IDUA primer pair b/c as previously
described (12). The ampliﬁed DNA was diluted 1:20 and
2 ml were used for a second PCR with primer pair b/c for the
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Primer c was radioactively labeled with
32P-phosphate at its
50end. All the PCR of IDUA were carried out in 1.5 mM
MgCl2 and 5% DMSO. The ampliﬁed products were ana-
lyzed by electrophoresis in 5 or 10% polyacrylamide/7 M
urea gels. The assignment of the bands observed was con-
ﬁrmed by sequencing of the DNA extracted from the gel.
Results are representative of at least three independent
experiments.
Real-time RT–PCR
Three sets of speciﬁc primers were designed, enabling the
ampliﬁcation of a single speciﬁc product at a time (see Figure
3a). The sense primers were ‘Pre-mRNA’, ‘Authentic
mRNA’ and ‘Latent mRNA’ (see Supplementary Material).
The antisense primer used in all sets was CAD primer b.
Total RNA was prepared as described above, and cDNA
was synthesized from 0.2 mg of total RNA. cDNA (5 mlo f
a 1:20 dilution) was mixed with 10 mlo f2 · SYBR MIX
(ABgene), the appropriate forward and reverse primers
were added to 150 nM in a ﬁnal volume of 20 ml. Ampliﬁca-
tion was carried out using an ABI PRISM 7700 sequence
detector (Applied Biosystem). The cycling conditions com-
prised 15 min of polymerase activation at 95 C, 40 cycles
at 95 C for 10 s, 65 C (for Authentic and Pre-mRNA), or
68 C (for Latent mRNA) for 20 s, and 74 C for 15 s. The
ampliﬁcation cycles were followed by a melting curve
cycle. The ﬁnal products were subjected to electrophoresis
in 10% polyacrylamide/7 M urea gels to validate the produc-
tion of a single amplicon per reaction. Each assay included
(in duplicate) a no-template-control and a mock-transfection
RNA. Results from at least three independent experiments
were averaged, and the standard errors are indicated.
Data analysis
Data of the ampliﬁed splicing products corresponding to pre-
mRNA, authentic mRNA, and latent mRNA, were exported
as a tab-delimited text ﬁle to a Microsoft Excel spread
sheet for further analysis. The efﬁciencies of the reactions
were determined by a linear regression method as described
in Ref. (31) using the LinReg program. A midpoint threshold
was then established, as suggested in Ref. (32), for each of
the three amplicons arising from a given cDNA. The expres-
sion levels (Q) were then determined according to the equa-
tion Q ¼ E C1, where E is the reaction efﬁciency and Ct is the
cycle threshold. To verify that all transfections were done
under similar conditions, we analyzed two reference genes
(SDHA and b-actin) using the Genorm program (33). The
ampliﬁcation efﬁciency of the reference genes was determ-
ined using the standard curve method.
RESULTS
Mutating all AUG codons upstream of a latent 50 splice
site elicits latent splicing
To test for the effect of removal of AUG codons on SOS, we
generated mutant minigene constructs derived from the previ-
ously described (12) wild-type CAD1 construct (Figure 1a),
in which different ATGs were mutated (see Supplementary
(a)
(b)
(c)
Figure 1. A start codon is required to sustain SOS. (a) A schematic
representation of the CAD1 minigene. Start codons (ATG) and stop
codons of reading frame 0 and +1 are drawn above and below the scheme,
respectively. S designates a stop codon followed by a number that
represents its distance in nucleotides from the authentic 50 splice site.
Open boxes, exons; lines, introns; narrow box, latent exon; a, b, c, j and k,
PCR primers used to detect the respective splicing products. (b)
Eliminating all four AUG codons from a wild-type CAD construct elicits
latent splicing. Gel electrophoretic analysis of RT–PCR DNA fragments
obtained from CAD mini genes. The presence of wild-type or mutated
start and stop codons in each construct is marked by a + or  ,
respectively (see Supplementary Table 1S). Bands corresponding to
precursor and latent CAD fragments amplified with primer pair c/b (upper
panel) or corresponding to the precursor, authentic and latent mRNA
amplified with primer pair a/b (lower panel) are indicated by schematic
drawings on the left. (c) Splicing of IVS1 is not affected upon activation
of latent splicing in CAD Mut9 and Mut46. The splicing pattern of IVS1
was analyzed by RT–PCR with primer pair j/k, targeted to sequences
flanking IVS1.
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(IVS N). It is preceded by four stop codons (S25, S34, S79,
S91) in reading frame 0 which initiates at ATG1. Reading
frame 0 contains an additional ATG sequence (ATG2). Read-
ing frame +1 contains two ATG sequences (ATG3 and
ATG4) and a downstream stop codon (S85).
The effect of the mutations on latent splicing was analyzed
by transient transfections and RT–PCR analyses of the
expressed isolated RNAs. PCR analyses of CAD RNAs
were performed using an intronic primer, primer c, and pri-
mer b, which is complementary to a sequence within the
downstream exon N + 1. These primers are expected to amp-
lify the pre-mRNA and latent RNA but not the normally
spliced RNA. We also performed RT–PCR analysis using pri-
mer pair a/b, where primer a spans the junction between exon
2 and exon N (Figure 1a). These primers amplify the authen-
tic and latent mRNA products, as well as the pre-mRNA. For
estimating transfection efﬁciency, we used GFP DNA, which
was cotransfected with the CAD minigene constructs as an
internal standard. Transfection with the wild-type CAD1
mini gene construct gave rise to a 296 bp amplicon when
ampliﬁed with primer pair c/b (Figure 1b, upper panel, lane
1), or a 428 bp amplicon when ampliﬁed with primer pair
a/b (Figure 1b, lower panel, lane 1), each representing
CAD1 pre-mRNA. Notably, no band representing latent
RNA (196 bp with primer pair b/c or 329 bp with primer
pair a/b) was observed. This result indicates that splicing at
the latent 50 splice site of pre-mRNA transcribed from the
wild-type CAD1 construct was suppressed, as expected
from the SOS hypothesis for a pre-mRNA transcript having
in-frame stop codon(s) upstream of a latent 50 splice site.
RT–PCR analysis of CAD1-Mut9 RNAs, in which all four
stop codons had been eliminated by frame shifting (12),
gave rise to the amplicons representing latent CAD RNA:
196 bp with primer pair b/c and 329 bp with primer pair a/
b (Figure 1b, lane 2, upper and lower panels, respectively).
The involvement of AUGs in the SOS mechanism is shown
by eliciting latent splicing in a mutant construct where all
four ATGs were mutated, leaving all stop codons unchanged
(CAD1-Mut46; see Supplementary Table 1S). Figure 1b, lane
3, shows that the occurrence of latent splicing in this mutant
indicates that the stop codons in CAD1-Mut46 are not recog-
nized as such by the SOS mechanism in the absence of a start
codon sequence. Notably, the levels of authentic mRNA (the
204 bp amplicon in Figure 1b, lower panel) were not signiﬁc-
antly affected by the mutations, indicating that the appear-
ance of latent splicing cannot be attributed to changes in
the level of expression of the mutant constructs. Moreover,
the splicing pattern of the intron upstream of IVSN is not
affected by the mutations (Figure 1c). We can therefore con-
clude that a start codon sequence may serve as a reference
point that deﬁnes the reading frame for SOS.
(a)
(b)
(c) (d)
(e)
Figure 2. SOS depends predominantly on the first AUG. (a) Latent splicing
in mutants harboring a single AUG codon. The presence of wild-type or
mutated start and stop codons in each construct is marked by + or  ,
respectively; Mut56 and Mut57 harbor silent mutations upstream and
downstream of AUG1, respectively (see Supplementary Table 1S). (b) Cells
were transfected with CAD mini gene constructs as indicated. Twenty-four
hours post-transfection cells transfected with CAD-Mut45 (lanes 3–6) were
treated with CHX (20 mg/ml) for the indicated lengths of time. (c and d) Cells
were treated with siRNA against hUpf1 as indicated, or with siRNA against
luciferase (Luc) as control. Forty eight hours after RNAi treatment, cells were
transfected with b-globin Ter39 (a mutant construct expressing b-globin
mRNA having a PTC at position 39) (c, lower panel), or with CAD mini gene
constructs as indicated, and the expression of CAD, hUpf1 and GFP RNAs
were carried out by RT–PCR analyses (d). Western blot analyses were carried
out using antibodies (Ab) against hUpf1, ADAR1 and CBP80, as indicated (c,
upper panel). The percentage of hUpf1, normalized to the levels of CBP80
and to the levels of proteins in the mock-transfected lane is indicated below
the corresponding bands. (e) Cells were transfected with CAD mini gene
constructs as indicated. The presence or absence of start and stop codons is
marked by + and  , respectively. Mut52 and Mut53 contain a mutated Kozak
sequence (see Supplementary Table 1S). RNA analyses, lettering and
symbols are as in Figure 1.
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Next we asked which of the four AUG sequences is affecting
SOS. To this end we generated four mutant constructs in
which all stop codons and only one ATG sequence were
retained (Supplementary Table 1S). As can be seen in
Figure 2a, latent splicing in the mutant that retained AUG1
(the translation initiation codon sequence) could hardly be
detected (CAD1-Mut45; Figure 2a, lane 3; see quantitative
PCR below). In contrast, latent splicing was elicited from
the remaining mutants, each harboring one of the remaining
start codon sequences (AUG 2–4) but lacking AUG1
(CAD1-Muts 47, 42 and 48; Figure 2a, lanes 4–6, respect-
ively; for quantitation see below). To demonstrate that the
effect of the mutations on latent splicing was owing to the
mutation of the AUG sequence and not the mutation per se,
we show that silent point mutations in the neighborhood of
AUG1, six codons downstream (Mut56) or six codons
upstream (Mut57) of AUG1, did not elicit latent splicing
(Muts 56, 57; Figure 2a, lanes 7, 8, respectively, for quantita-
tion see below). Notably, latent splicing was not suppressed
in Mut47 although it contains an AUG sequence in frame
0. This observation indicates that an AUG sequence in
frame 0 by itself is not sufﬁcient to sustain SOS. Rather,
the ﬁrst AUG sequence, which is the translation initiation
codon sequence for the CAD protein, appears to play a
predominant role in suppression of CAD latent splicing.
Evidently, however, AUG1 is not sufﬁcient to confer the
tight regulation exhibited by SOS in the wild-type CAD con-
struct because latent splicing in Mut45, which contains only
AUG1, could be detected, though at a very low level
(Figure 2a, lane 3; for quantitation see below). Having four
in-frame stop codons and a translation initiation codon
sequence, the low level of this RNA could have been attrib-
uted to NMD (14). However, treatment with cycloheximide
(CHX; an inhibitor of protein synthesis), which is known to
abrogate NMD (12,19,34,35), did not increase signiﬁcantly
the level of latent mRNA in Mut45 (Figure 2b). It should
be pointed out that NMD is abrogated under these conditions,
as evidenced by the upregulation of b-globin Ter39 cotrans-
fected with the wild-type CAD1 construct (12,19) and (Sup-
plementary Figure 1S). We have further validated that the
low level of latent splicing in CAD1-Mut45 could not be
attributed to NMD by siRNA-directed downregulation of
hUpf1. Western blot analyses revealed that RNAi of hUpf1
downregulated its expression to  1%, while the expression
of CBP80 and ADAR1 (reference proteins in the same
molecular-weight range as hUpf1) were not signiﬁcantly
affected (Figure 2c, upper panel). As previously shown
(19), downregulation of hUpf1 by RNAi did not elicit latent
splicing in CAD1 (Figure 2d, compare lanes 2 and 3). Under
these conditions NMD is abrogated, as evidenced by upregu-
lation of b-globin Ter39 (Figure 2c, lower panel). As can be
seen in Figure 2d, even when NMD was abrogated by down-
regulation of hUpf1 by RNAi, the level of latent RNA of
Mut45 did not increase (compare lanes 5 with 6). We can
therefore conclude that the low level of latent RNA obtained
in Mut45 most likely reﬂects the relative importance of the
ﬁrst AUG sequence in the regulation of SOS. In this context,
it should be pointed out that latent splicing in wild-type
CAD1 and in CAD mutants having all AUG sequences and
variable numbers and locations of intronic in-frame stop
codons could not be detected (12). Furthermore, the lack of
appearance of latent splicing in such constructs could not
be attributed to NMD because treatment with inhibitors of
NMD or downregulation by RNAi of the NMD genes
hUpf1 and hUpf2 did not elicit latent splicing (12,19) (see
also Figure 6a, lane 6, and Supplementary Figure 1S). The
reason why a mutant construct having only the ﬁrst AUG
sequence appears to have escaped SOS, though to a low
degree, is not yet understood. However, in Mut51, which har-
bors all four stop codons and in which AUG1 and AUG2 are
retained while AUG3 and AUG4 have been removed, the
tight regulation of SOS seems to be maintained (Figure 2e,
lane 3).
We further asked whether the Kozak consensus sequence
(36) may play a role in the deﬁnition of the reading frame
for the SOS machinery. To this aim we generated two mutant
constructs (Mut52 and Mut53) in which the Kozak sequence
CCCCATGG ﬂanking ATG1 was mutated to CTCCATGT.
Mut52 contains only AUG1 and Mut53 contains both
AUG1 and AUG2. As can be seen in Figure 2e, latent spli-
cing in Mut52 and Mut53 could not be detected (lanes
4 and 5, respectively). Taken together, we can conclude
that although SOS requires an AUG sequence as a reference
starting point, the ﬁrst AUG sequence is necessary but not
sufﬁcient to exert full suppression of latent splicing.
Optimization of product-specific primer
pairs for quantitative PCR
For quantitation of latent splicing in the AUG mutant con-
structs we used real time PCR analysis. For this aim we
designed primer pairs such that each should speciﬁcally
identify only one of the expected splicing products
(Figure 3a). The sense primers for the ‘authentic’ and ‘latent’
mRNAs span the respective splice junctions. The sense pri-
mer for the ‘pre-mRNA’ is an intronic sequence downstream
of the latent 50 splice site. The antisense primer for all three
pairs was primer b in ExN+1. All three species were identi-
ﬁed simultaneously by the sense primer a (in ExN) and pri-
mer b. To demonstrate the efﬁcacy of this approach we
analyzed the splicing patterns of RNAs expressed from the
CAD2 and CAD2-Mut1 minigenes. The CAD2 construct
has two in-frame stop codons between the normal and the lat-
ent 50 splice site, and CAD2-Mut1 is a construct in which
both stop codons have been eliminated (12). As shown
in Figure 3b, when RT–PCR analysis was performed using
primer pair a/b, CAD2 gave rise to the authentic mRNA
and traces of pre-mRNA, whereas CAD2-Mut1 gave rise to
both authentic and latent mRNAs, as well as pre-mRNA
(lane 3; for a discussion on the expression of CAD2-Mut1
RNA see below). Figure 3c shows the analyses using the spe-
ciﬁc primer pairs of RNAs expressed from both constructs. In
both cases, primer pair ‘pre-mRNA/b’ gave rise to a single
PCR product of 171 nt, which corresponds to the pre-
mRNA (lanes 2 and 5), and primer pair ‘authentic/b’ gave
rise to a single PCR product of 97 nt, which corresponds to
the authentic mRNA (lanes 3 and 6). Primer pair ‘latent/b’
revealed a single band of 96 nt, which corresponds to latent
mRNA, only in cells transfected with CAD2-Mut1 (lane 7)
Nucleic Acids Research, 2006, Vol. 34, No. 12 3425but none in cells transfected with CAD2 (lane 4). We use
hereafter the term ‘fully suppressed’ to indicate that quantit-
ative real time RT–PCR analyses, which could resolve quant-
ities of latent nonsense RNA four to ﬁve orders of magnitude
lower than that of the latent spliced CAD2 Mut1 mRNA
(Supplementary Figure 2S), did not reveal latent splicing in
the wild-type constructs. These results validate the speciﬁcity
of this approach.
Quantitative analyses of the effect of stop codon
removal on latent splicing
In view of the speciﬁcity of the described primer sets, quant-
itation was performed using real time PCR analysis. We ﬁrst
analyzed the transcripts expressed from CAD1, CAD1-Mut9,
CAD2 and CAD2-Mut1. The qualitative analyses of the spli-
cing patterns of these transcripts, using RT–PCR and nucle-
ase S1 mapping analyses, have been described by Li et al.
(12). These experiments showed that latent splicing from
the constructs harboring intronic in-frame stop codons
(CAD1 and CAD2) were fully suppressed. Whereas when
the stop codons were eliminated by frame-shifting (CAD1-
Mut9) or point mutations (CAD2-Mut1), latent splicing
could be readily observed. We have now veriﬁed these results
using the product-speciﬁc PCR. Equal aliquots of cDNA ori-
ginating from transient transfections of 293T cells with each
(c)
(b)
(a)
Figure 3. Product-specific real-time PCR. (a) A schematic representation of
the underlying design of the quantitation method. Authentic and latent
mRNAs are specifically hybridized to PCR primers that flank the junction
between a sequence upstream of the respective 50 splice site and a sequence in
the downstream exon. The specificity for the pre-mRNA stems from the
location of the sense primer downstream of the latent site. Wide box, exon;
line, intron; narrow box, latent exon. (b) Gel electrophoretic analysis of RT–
PCR products from transcripts of wild-type CAD2 (lane 2) and the stop-
codon-less CAD2-Mut1 (lane 3) constructs. Bands corresponding to precursor
(428 bp), authentic (203 bp) and latent (328 bp) CAD fragments amplified
with primer pair a/b are indicated by schematic drawings on the right. (c)
RNA isolated form cells transfected with CAD2 (lanes 2–4) or with CAD2-
Mut1 (lanes 5–7) were analyzed with the specific primer pairs as indicated:
The precursor-specific primer pair (lanes 2 and 5); the authentic-specific pair
(lanes 3 and 6) and the latent-specific pair (lanes 4 and 7). PCR products were
analyzed on a denaturing 7.5% polyacrylamide gel.
Figure 4. Quantitative analyses of the effect of stop codon removal on latent
splicing. RNA isolated from cells transfected with the indicated CAD
constructs were analyzed by real-time PCR using the specific primer pairs. (a)
Gel electrophoresis of the real time PCR products with the latent-specific
primer pair. No band is detected in transfections with CAD1 (lane 1) or
CAD2 (lane 3), whereas the mutated constructs lacking the intronic stop
codons gave rise to a single band of the expected size (96 bp; lanes 2 and 4,
respectively). NTC, no-template-control. (b) Quantitation of the real-time
PCR results. Fluorescence reading from the ‘authentic/b’ primer pair was
defined as 1.00 and all other readings were scaled accordingly. Note that
latent splicing in the wild-type constructs, CAD1 and CAD2, is fully
suppressed. Error bars represent SE of three independent experiments.
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speciﬁc primer pairs described in Figure 3a and subjected to
real time PCR analysis. The generation of a single product
from each of the primer pairs was veriﬁed by performing a
melting curve and by gel electrophoretic analysis at the end
of each ampliﬁcation reaction. Using the ‘latent/b’ primer
pair, no latent splicing arising from the wild-type CAD1
and CAD2 pre-mRNAs could be detected (Figure 4a, lanes
1 and 3, respectively). However, in CAD1-Mut9 and
CAD2-Mut1 where the intronic stop codons had been elimin-
ated, latent splicing was observed (Figure 4a, lanes 2 and 4).
The ﬂuorescence readings from the real-time PCR cycles
were then used to calculate the relative quantities of the dif-
ferent RNA products (authentic, latent and pre-mRNA). The
level of authentic mRNA was deﬁned as 1.00, and used to
normalize the ﬂuorescence acquired in the latent and pre-
mRNA reactions (Figure 4b). Latent splicing obtained from
CAD1-Mut9 was 3% of the authentic splicing event, whereas
latent splicing in the wild-type CAD1 pre-mRNA was fully
suppressed, in agreement with the qualitative analyses
(Figure 1b). No signiﬁcant change was observed in the levels
of the pre-mRNA expressed from CAD1 and CAD1-Mut9
(0.18 and 0.25, respectively). The measurement of latent spli-
cing in the wild-type CAD2 pre-mRNA showed that it was
fully suppressed, whereas latent splicing from the stop-
codon-less CAD2-Mut1 was 0.41 of the authentic splicing
event obtained from that construct. This high level of latent
splicing (relative to the 0.03 in CAD1-Mut9) can be attrib-
uted to the fact that for generating CAD2-Mut1 the TGA
located within the authentic 50 splice site was mutated to
TGG. It should be pointed out, however, that activation of lat-
ent splicing in CAD2-Mut1 could not be attributed to this
mutation because latent splicing in another construct
(CAD2-Mut2), harboring the same mutation but maintaining
another in-frame stop codon further downstream, was fully
suppressed (12). Also, two mutant constructs both having
the ﬁrst stop codon mutated to TGG and the second stop
codon mutated to either TAG or TAA did not elicit latent
splicing [see CAD2-Mut10 and CAD2-Mut11 in (12)].
Another consequence of the TGA to TGG mutation within
the authentic 50 splice site is that the level of CAD2-Mut1
pre-mRNA was elevated to 1.01, compared with 0.27 in the
wild-type construct CAD2 (Figure 4b; see below a discussion
on the level of pre-mRNA in the various mutants). These
results reinforce our previous qualitative analyses of latent
splicing from these constructs (12), and provide quantita-
tive validation to the tight regulation exerted by the SOS
mechanism.
Quantitative analyses of the effect of AUG
removal on latent splicing
We next used the same real time PCR procedure to quantify
the latent splicing events obtained from mutants of CAD1 in
which part or all the four ATGs in the construct were
mutated, but all stop codons were retained (Figure 5). In
order to compare the relative quantities of latent mRNA
obtained from each of the mutant constructs, the levels of lat-
ent mRNAs were expressed as a percentage of the authentic
mRNA obtained from the corresponding construct. These
values were then normalized to the level of latent mRNA
from CAD1-Mut9. The highest activation of latent splicing
was observed in CAD1-Mut46, a construct where all four
ATGs were eliminated and all stop codons maintained. This
level of latent splicing was 1.5-fold higher than that in
CAD1-Mut9, where all ATGs were retained and all stop
codons were mutated. Signiﬁcantly lower levels of latent spli-
cing were observed from constructs in which all but one of
the ATGs were mutated. The lowest level (0.24) was in
CAD1-Mut45 in which the ﬁrst ATG was retained. Higher
levels (0.38, 0.49, and 0.48) were observed in mutants 47,
42 and 48, where the respective second, third and fourth
ATG was retained. To demonstrate that the effect of the
mutations on latent splicing was due to the mutation of the
ATG sequence and not the mutation per se, we show that
when a silent point mutation was made six codons down-
stream of ATG1 (Mut56), latent splicing was fully suppressed
(Figure 5). These results provide a quantitative validation to
the qualitative data shown in Figures 1b and 2a. In this con-
text, it should be pointed out that the levels of authentic
mRNAs were not dramatically affected in the different
ATG mutants (Supplementary Figure 3Sa, b). Furthermore,
there appears to be no direct correlation between the occur-
rence of latent splicing and the level of pre-mRNA (Supple-
mentary Figure 3Sc, d). For example, in comparison to the
level of pre-mRNA in wild-type CAD1, which does not
show latent splicing, the level of pre-mRNA in CAD1-
Mut46 increased by a factor of 1.4 and that in CAD1-
Mut48 dropped down to 0.3, while both mutants gave rise
to latent splicing. Taken together, our ﬁndings demonstrate
Figure 5. Quantitative analyses of the effect of start codons removal on latent
splicing in the indicated constructs. The presence of wild-type or mutated
start and stop codons in each construct is marked by + or  , respectively (see
Supplementary Table 1S).. Latent splicing was calculated for each of the
indicated constructs as described in Figure 4. Latent splicing from CAD1-
Mut9 was defined as 1.00 and all other measurements were scaled
accordingly. Error bars represent SE of three independent experiments.
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regulation by the SOS machinery. Evidently, however, at
least in the case of the CAD gene, each individual AUG
sequence on its own was not sufﬁcient to confer tight
SOS. On the other hand, the fact that the ﬁrst AUG sequence
was the most effective in suppressing latent splicing, in-
dicates the importance of the ﬁrst AUG in deﬁning the
reading frame used by the SOS mechanism in exerting its
activity.
Treatment with pactamycin elicits latent splicing in
wild-type CAD1 and CAD2 pre-mRNAs
Pactamycin, a drug known to inhibit translation in bacteria
and eukaryotes, has been shown to fold up within the ribo-
some to mimic a stacked RNA fold (37). It may thus be pos-
sible that pactamycin may interfere with putative element(s)
involved in the SOS mechanism. In the following experiment,
293T cells were transfected with wild-type CAD1 minigene
construct and treated with pactamycin at 24 h post-
transfection. Figure 6a shows that increasing amounts or
longer treatment with pactamycin resulted in increasing
levels of latent splicing in the wild-type construct CAD1
(Figure 6a, lanes 3–5). For a quantitative veriﬁcation of
these results we measured the effect of pactamycin on the
splicing patterns of CAD1 and CAD2 pre-mRNAs by the
real-time PCR procedure as described above. Cells transfec-
ted with each of these wild-type constructs were treated with
pactamycin (3 mg/ml for 4 h). This treatment activated latent
splicing in both constructs, yet to a different extent
(Figure 6b). The measured levels of latent splicing were
0.69 and 0.19, for CAD1 and CAD2, respectively, relative
to that obtained for CAD1-Mut9, a mutant lacking all in-
frame stop codons, measured in a parallel experiment without
pactamycin treatment. Importantly, treatment with CHX,
another drug that inhibits translation did not activate latent
splicing in wild-type CAD1 (Figure 6a, lane 6). Furthermore,
treatment of cells transfected with CAD1 with the translation
inhibitor hygromycin B, or with the bacterial translation
inhibitor tetracycline as a control, did not elicit latent splicing
(Figure 6c, lanes 4 and 5, respectively).
Endogenous genes are subject to SOS
The ﬁnding that pactamycin abrogates SOS in transfection
experiments, provides us with an opportunity to study
whether endogenous, unmutated, genes are subject to SOS.
This possibility has already been indicated by Miriami
et al. (11), where latent splicing in the endogenous CAD
gene product was elicited by heat treatment. Here, we ﬁrst
tested the effect of pactamycin on the expression of the endo-
genous CAD gene in normally grown Syrian hamster cells. In
parallel, we tested the effect of CHX, hygromycin-B, and the
bacterial translation inhibitor tetracycline as control.
Figure 7a shows analyses by RT–PCR of CAD RNA
expressed from the drug-treated cells. Whereas no latent spli-
cing was expressed from the untreated cells, or from cells
treated with either CHX, hygromycin-B or tetracycline, treat-
ment with pactamycin elicited latent splicing. These results
are similar to those obtained with transfected minigenes.
Next, we tested the effect of pactamycin on the expression
of the human endogenous a-L-iduronidase (IDUA) gene,
minigene constructs of which were previously reported to
be under the control of SOS (12,19). Figure 7b shows that,
in human 293T cells grown under normal conditions, latent
splicing of the endogenous IDUA pre-mRNA was fully sup-
pressed. However, when the cells were treated with pactamy-
cin (3 mg/ml for 4 h), latent splicing was elicited as detected
by RT–PCR analysis. These ﬁndings indicate that SOS is
likely to be a mechanism that operates naturally on endogen-
ous genes.
(a)
(b)
(c)
Figure 6. Pactamycin elicits latent splicing in wild-type CAD RNAs. (a)
Cells were transfected with CAD mini gene constructs as indicated. The
presence of wild-type or mutated start and stop codons in each construct is
marked by + or  , respectively (see Supplementary Table 1S). Twenty-four
hours post-transfection, cells transfected with CAD1 (lanes 3–6) were treated
with pactamycin (lanes 3–5) or CHX (lane 6), as indicated. RT–PCR products
were analyzed on a denaturing 10% polyacrylamide gel. (b) Quantitative
analysis of latent splicing was carried out as described in Figure 5 using RNA
from cells transfected with wild-type CAD1 and CAD2 and treated with 3 mg/
ml pactamycin for 4 h. Error bars represent SE of three independent
experiments. (c) Transfection experiments were performed with CAD1 for 24
h. The cells were treated for 2 h with pactamycin (pact; 3 mg/ml; lane 3),
tetracycline (tet; 20 mg/ml; lane 4) and hygromycin B (hyg B; 20 mg/ml; lane
5) and RNA was extracted. RT–PCR products were analyzed on a denaturing
5% polyacrylamide gel.
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Given that the removal of the AUG sequences and treatment
with pactamycin elicited latent splicing, raised the possibility
that translation initiation is involved in SOS. To address this
possibility we tested the effect of 4E binding protein (4E-
BP1) on latent splicing. This protein disrupts an important
interaction within the translation initiation complex between
the cap-bound eIF4E and the ribosomal-subunit-associated
eIF4G, which is required for cap-dependent translation in
eukaryotes (38). Transfection of Syrian hamster cells with
the 4E-BP1 construct (27,28) together with a GFP construct
did not elicit latent splicing in the endogenously expressed
CAD pre-mRNA (Figure 8a, lane 2), whereas treatment
with pactamycin did elicit latent splicing (Figure 8a, lane
4). Notably, the effect of pactamycin on SOS was independ-
ent on translation initiation because the drug elicited latent
splicing when translation initiation was inhibited (Figure 8a
lane 3). Inhibition of translation under these conditions was
exhibited by a 10-fold downregulation of the GFP protein
expressed from the cotransfected GFP construct (Figure 8a,
right panel).
The above results show that steady-state translation initi-
ation is not involved in SOS. We have further tested whether
SOS could be affected by the pioneer round of translation,
because it has been previously shown that this reaction is
not inhibited by 4E-BP1. On the other hand, the pioneer
round of translation is dependent on eIF2a, which is an integ-
ral part of the pioneer round of translation and steady-state
translation (39). To this end we monitored the effect of a
dominant negative phosphomimetic mutant of the a subunit
of eIF2 (eIF2a S51D), which is constitutively inactive in
translation initiation (29). Transfection of Syrian hamster
cells with either the eIF2a S51D or the wild-type constructs
did not elicit latent splicing in the endogenously expressed
CAD pre-mRNA (Figure 8b, lanes 2 and 3), indicating that
SOS is independent on the pioneer round of translation in
addition to being independent on steady-state translation.
Notably, the effect of pactamycin on SOS was independent
on the pioneer round of translation initiation, as latent spli-
cing occurred even under conditions inhibiting this transla-
tion (Figure 8b, lane 4). Inhibition of translation under
these conditions was exhibited by the  100-fold downregula-
tion of the GFP protein expressed from the cotransfected GFP
construct (Figure 8b, right upper panel). As expected, NMD
(a)
(b)
(c)
Figure 8. SOS is not dependent on translation initiation. (a) SOS is not
dependent on steady-state translation. Left panel: RT–PCR analyses of
endogenous CAD RNA expressed in cultured Syrian hamster 165-28 cells
transfected with 4E-BP1 and GFP constructs, with or without pactamycin
treatment as indicated. For comparison, we show the expression of latent
RNA from 293T cells transfected with the wild-type CAD1 construct treated
with pactamycin (lane 5). Right panel: western blot analysis of total proteins,
prepared from cells transfected as indicated, were performed using antibodies
against 4E-BP1, GFP, and a-tubulin. The percentage of GFP, normalized to
the levels of a-tubulin and to the levels of proteins in the mock-transfection
lane, is indicated below the corresponding bands. (b) SOS is not dependent on
the pioneer round of translation. Left panel: RT–PCR analyses of endogenous
CAD RNA expressed in cultured Syrian hamster 165-28 cells transfected with
eIF2a (wt) or with a dominant negative mutant of eIF2a (S51D), and GFP
constructs, with or without pactamycin treatment as indicated. Right panel:
western blot analyses of total proteins, prepared from cells transfected as
indicated, were performed using antibodies against HA, GFP and a-tubulin.
The percentage of GFP, normalized to the levels of a-tubulin and to the levels
of proteins in the wild-type-transfection lane is indicated below the
corresponding bands. (c) NMD is abrogated by eIF2a S51D. Cultured Syrian
hamster 165-28 cells were cotransfected with b-globin (wild-type or Ter 39)
constructs, GFP construct and with eIF2a (wild-type or S51D) as indicated.
RT–PCR analysis of b-Globin mRNA was performed as described in
Figure 2c. Abrogation of NMD by eIF2a–S51D is evidenced by the
upregulation of b-globin Ter39 mRNA.
(a)
(b)
Figure 7. Pre-mRNAs expressed from endogenous genes are subject to SOS.
(a) Cultured Syrian hamster 165-28 cells were treated with antibiotics as in
Figure 6, and RT–PCR analysis of endogenous CAD RNAs was performed
using the b/c primer pair. Latent splicing was elicited only by treatment with
pactamycin. For comparison we show the expression of latent CAD mRNA in
293T cells transfected with the wild-type CAD1 construct and treated with
pactamycin (lane 1). Cloning and sequencing of the PCR products of primer
pair b/c revealed that the lower band in the 296 bp region represents the CAD
pre-mRNA, while the upper band represents a non-relevant endogenous gene.
(b) Human 293T cells were treated with pactamycin and radioactive RT–PCR
analysis of the endogenous IDUA RNAs was carried out using IDUA-specific
primer pairs (see Primers in Supplementary material) using the 50 32P-lebeled
antisense primer. The IDUA PCR products were revealed by electrophoresis
in a denaturing gel and autoradiography.
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upregulation of b-globin Ter39 in cells treated with eIF2a
S51D (Figure 8c). We can therefore conclude that translation
initiation is not likely to be involved in SOS.
DISCUSSION
Most human genes harbor a substantial number of intronic
latent 50 splice sites (8). Suppression of splicing (SOS) at
such sites was shown to be sustained by upstream intronic
stop codons in the reading frame of the upstream exon
(12). The occurrence of SOS can therefore be rationalized
by the necessity to maintain the translatability of mRNAs,
thereby eliminating the production of toxic nonsense
mRNAs. The recognition of an ORF at the level of pre-
mRNA raises several mechanistic questions which are yet
unanswered. One crucial question is the requirement for a
starting point that deﬁnes the reading frame, as without a
register to establish a reading frame it would be difﬁcult to
understand how SOS could recognize in-frame stop codons.
Here we show that AUG sequences are essential for the
tight regulation by SOS. Speciﬁcally, we show that mutating
all AUG sequences upstream of a latent 50 splice site elicited
latent splicing in a CAD construct in which all upstream stop
codons were retained. We further show that the ﬁrst AUG
sequence plays a predominant role in sustaining SOS, yet it
is necessary but not sufﬁcient to impose the tight regulation
by SOS, which is observed in the wild-type constructs. We
are aware that this mechanism is difﬁcult to envision because
it implies that the reading frame of the mRNA is recognized
prior to splicing. Nevertheless, the present study reinforces
the concept of SOS and provides an initial mechanistic
insight into this mechanism.
The effect of pactamycin on SOS
Our results have shown that SOS and the effect of pactamycin
on SOS are not dependent on translation initiation. Therefore,
the effect of pactamycin on latent splicing is not linked to its
role in protein translation, but rather to a direct effect on SOS.
A possible clue for this effect may be inferred from the fact
that hygromycin B did not elicit latent splicing in the trans-
fected as well as the endogenous CAD genes (Figures 6c
and 7a, lane 5, respectively), and from the difference in the
mode of interaction of pactamycin and hygromycin B with
the ribosome. While both drugs occupy close locations on
the bacterial 30S ribosomal subunit, they differ in their bind-
ing characteristics to the 16S RNA (37). In particular, upon
binding to the ribosome, pactamycin folds up to mimic a
stacked RNA dinucleotide that lies in a position originally
occupied by the last two bases of the E site codon in the nat-
ive structure (37). It is therefore possible that by virtue of the
capacity of pactamycin to recognize an RNA-fold, rather than
speciﬁc bases or sequences, it binds to the pre-mRNA. By
doing so, probably by employing molecular mimicry, it
may interfere with binding of an element(s) that deﬁne the
starting point for a putative surveillance machine that under-
lies the SOS mechanism. This view is strengthened by our
observation that the effect of pactamycin on SOS is independ-
ent of translation initiation—both the pioneer round of trans-
lation and the steady-state translation (Figure 8)—indicating
that its effect on SOS is not likely to be related to its effect
on protein synthesis.
The relationship between SOS and other RNA
surveillance mechanisms
In addition to SOS, two cellular pathways have been
described as capable of eliminating the inclusion of pre-
mature translation termination codons (PTCs) in mature
mRNAs—NMD and NAS. Unlike SOS, which responses to
intronic in-frame stop (nonsense) codons and appears to func-
tion in splicing of many normal genes, NMD and NAS are
responses to somatic or intentional mutations that introduce
nonsense codons into bona ﬁde exons. SOS is distinct from
NMD in additional important parameters. First, while NMD
is dependent on protein translation (20), or at least on a pion-
eer round of translation (40), SOS is not dependent on protein
synthesis. To this end, we have shown that SOS is not affec-
ted by the translation inhibitor CHX [Figure 6a, lane 6; Sup-
plementary Figure 1S; see also (12)]. Furthermore, SOS is not
affected by reagents that allow read-through of in-frame stop
codons, such as G-418 and suppressor tRNAs (12,19). In con-
trast, all the above reagents were shown to abrogate NMD
thereby increasing the levels of PTC-harboring mRNAs (Sup-
plementary Figure 1S and Refs (12,34,35,41,42)). Second,
SOS is distinct from NMD in its response to a dominant neg-
ative mutant of NMD-associated hUpf1 gene, because
expression of this mutant, which was shown to abrogate
NMD (43–45), did not elicit latent splicing in wild-type
CAD1 pre-mRNA (19). Furthermore, in contrast to NMD,
SOS is not affected by RNAi treatment of the NMD genes
hUpf1 (Figure 2d) and hUpf2 (19). Although SOS and
NMD appear to be two distinct surveillance mechanisms, it
is probable that if nonsense latent mRNAs are formed by
somehow escaping the SOS mechanism, they might be sub-
jected to the NMD pathway.
Are SOS and NAS functionally related? While NAS occurs
infrequently and is observed only with speciﬁc exons of par-
ticular mRNAs, SOS can be viewed as a mechanism that
ensures that only functional mRNAs are produced and it
appears to do so in most genes (8). Yet, both mechanisms
imply that mRNA reading frames can be recognized in the
nucleus prior to splicing. How this task is achieved is yet
an unresolved question. Nuclear translation (46) was invoked
for occurrences of NAS that were shown to be dependent on
protein translation (25), though an alternative mechanism,
which relies on cytoplasmic translation in conjunction with
shuttling splicing factors, was proposed (47). The dependence
of SOS on a translation initiation sequence might have
implicated protein translation in this splicing control process,
but our data exclude this possibility. Namely, we have shown
in this article and in our previous studies (12,19) that SOS is a
nuclear mechanism that affects splicing and is not affected by
translation inhibitors. Furthermore, we show here that inhibi-
tion of translation initiation by the eIF4E-binding protein
(4E-BP1), which inhibits steady-state translation (Figure 8a,
lane 2), or by eIF2a S51D, which inhibits both steady-state
translation and the pioneer round of translation (Figure 8b
lane 3), did not elicit latent splicing. In this sense SOS may
be related to the NAS in the Igk gene, which was shown to
be independent on protein synthesis (21). It thus remains to
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nized in the nucleus prior to splicing, regardless of the unre-
solved issue of nuclear translation (47). This recognition may
not necessitate ribosomes as deﬁned for protein synthesis,
but may be brought about by one or more ribosomal compon-
ents whose nuclear localization is not questionable, or by
yet unidentiﬁed nuclear components. The effects on SOS
observed in this study may thus be attributed to disruption
of the recognition of the ﬁrst AUG sequence by the SOS mech-
anism when such AUGs are mutated, and/or to alterations in
a speciﬁc RNA fold near this sequence caused by such muta-
tions. The recognition of a starting point for SOS may also be
hampered by drugs that, like pactamycin, adopt an RNA fold
and compete, presumably by molecular mimicry, for elements
of the surveillance machine that deﬁne the starting point.
Is SOS a general RNA surveillance mechanism?
A large body of literature has made it clear that 50 splice site
selection, which is essential for productive splicing events, is
controlled by a number of RNA and protein elements. Not
only that the ﬁnal number of such elements has not yet
been determined, a rule that assigns their relative weights
in deﬁning a given 50 splice site has not yet been formulated.
An apparently important factor that affects 50 splice site
selection is the compliance of the 50 splice site with the con-
sensus sequence, or its relative ‘strength’ as deﬁned by a
numerical score (48). Evidently however, not always a splice
site that scores higher is preferred when it can potentially
compete with an alternative weaker one. A striking example
is the CAD gene reported here, because the Shapiro and
Senepathy (48) score of the authentic 50 splice site (AG/
GTGACA) is 76.8, whereas that of the latent one (AG/
GTGGGT), which resides 125 nt downstream within the
intron, is 86. Yet, only the former is selected for splicing,
whereas splicing involving the latent one is fully suppressed.
We have therefore proposed that the occurrence or absence of
stop codons, which are in the reading frame of the upstream
exon, may constitute a factor that determines whether a
downstream legitimate 50 splice site would remain silent (lat-
ent) or be used for splicing (11,12).
The occurrence of this factor invoked SOS as a general sur-
veillance mechanism that should operate on all pre-mRNAs.
Thus far we have demonstrated the occurrence of SOS in two
constitutive gene products—CAD and IDUA (12,19). We
analyzed a large number of mutants of these genes and
found that the splicing patterns of all of them were consistent
with the SOS notion. The generality of the SOS mechanism
was also evaluated in a computerized survey for latent
50 splice sites. The dataset contained 2311 introns, in which
we found 10490 latent 50 splice sites. The utilization of
10045 (95.8%) of these sites for splicing would have led to
the inclusion of an in-frame stop codon within the resultant
mRNA. Statistical analysis further showed that the abundance
of in-frame stop codons upstream of latent 50 splice sites is
signiﬁcantly higher than that in introns that do not harbor lat-
ent 50 splice sites, and that the probability of the occurrence
of at least one in-frame stop codon upstream of a latent
50 splice site is higher than expected for a random distribution
(8,9). Finally, SOS has been shown to operate on endogenous
genes. For instance, latent splicing was elicited in the
endogenous CAD gene by heat treatment (11). Similarly,
we show here that treatment of cells with pactamycin abrog-
ates SOS and elicits latent splicing from CAD and IDUA
endogenous genes. These ﬁndings indicate that SOS is indeed
a general mechanism.
This view, however, has been challenged from both the
statistical and experimental aspects. In a different statistical
analysis, Zhang et al. (49) and Zhang and Chasin (50)
claim to have found no signiﬁcant enrichment of in-frame
stop codons between authentic 50 SS and downstream latent
50 SS. A key feature in their analysis is an estimate of the con-
tribution of the TRA (R ¼ G or A) triplet within the 50 SS to
the overall frequency of in-frame stop codons in the down-
stream introns. In doing so they assumed that the probability
of the TRA triplet to be in the reading frame of the upstream
exon is one third (0.333). The real frequency however, as
determined by bioinformatic analysis, is 0.182 for mammals
(51) and 0.2 (52) or 0.21 (53) for human databases. When
even the high value (0.21) is inserted in the equation used
by Zhang and Chasin (50) the resulting curve shows that
the probability of the occurrence of at least one in-frame
stop codon upstream of a latent 50 splice site is higher than
expected for random sequences. It seems therefore that both
different statistical analyses indicate the generality of SOS (9)
(for details see http://www.weizmann.ac.il/~cosper/suppinfo/
Miriami.pdf).
Another attempt was made to test the generality and mech-
anism of SOS by using a b-globin construct with an artiﬁcial
duplication of a 50 splice site (54). Assuming that the two
duplicated 50 splice sites in this wild-type construct are equi-
valent, the insertion of a stop codon between them was sup-
posed to suppress splicing from the proximal one in the
mutant construct. However, splicing from the proximal
50 splice site was not observed in both the wild-type and mut-
ant constructs. Only upon overexpression of SF2/ASF, prox-
imal splicing was observed for the wild-type construct and
hardly for the stop codon-containing mutants. From these
experiments the authors inferred that stop codons may not
have a general role in regulating pre-mRNA splicing. They
admit, however, that their artiﬁcial model may lack features
that may be required for SOS in native systems. For one rea-
son, this model may not be appropriate to test the generality
of SOS because proximal splicing was not observed in the
wild-type construct, although both its distal and proximal
50 splice sites are identical and are ﬂanked by identical
sequences. In addition, we report here that start codon
sequences, not necessarily the translation initiation codon
sequence but also other AUGs even in other reading frames,
are important elements in regulating SOS. It turns out that the
artiﬁcial b-globin construct used by Zhang and Krainer (54)
contains another open reading frame (ORF 1) that starts
with an AUG, which could allow proximal splicing even
when stop codons were inserted in ORF 0.
Based on the above arguments we can conclude that the
SOS mechanism appears to be general rather than a gene-
speciﬁc one. Our combined statistical and experimental data
strongly indicate that stop codons and AUG sequences should
be counted among the elements that regulate splicing through
SOS, although their relative weight is not known yet and may
vary among genes. These ﬁndings also imply the occurrence
of a nuclear scanning mechanism that is associated with SOS.
Nucleic Acids Research, 2006, Vol. 34, No. 12 3431In this sense, the observation that the introduction of PTCs
into exons have no effect on the rate of removal of ﬂanking
introns (55) may be interpreted as being consistent with an
SOS-associated nuclear scanning, because it appears that all
nuclear pre-mRNAs should be subject to scanning by the
SOS mechanism. We have shown here that, despite its appar-
ent independence on translation, SOS requires a start AUG
sequence as a register to establish the reading frame. It seems
therefore that AUG sequences can have additional role(s)
to their known role in translation, where the translation
machinery reads and translates the ORF deﬁned by the
AUG. Our results suggest the SOS mechanism as an addi-
tional machinery that is capable of recognizing the ORF for
the selection of the correct 50 splice site.
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